Results 231 to 240 of about 1,558,397 (364)
Mixed U-Net: Segmentation of focal liver lesions using a hybrid 2D and 3D model. [PDF]
Gao F, Hu Z, Xian J, Lu W.
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Low power and high-speed quadrate node upset tolerant latch design using CNTFET. [PDF]
Asiya S, S SK.
europepmc +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Enhancing Surgical Planning with AI-Driven Segmentation and Classification of Oncological MRI Scans. [PDF]
Martinez Guillermo A +3 more
europepmc +1 more source
DICER-ARGONAUTE2 Complex in Continuous Fluorogenic Assays of RNA Interference Enzymes
M. Bernard +2 more
openalex +2 more sources
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
A novel sub-differentiable hausdorff loss combined with BCE for MRI brain tumor segmentation using UNet variants. [PDF]
Visalakshi G, Mohan L.
europepmc +1 more source

